vigabatrin

Generic: vigabatrin

Labeler: amneal pharmaceuticals ny llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name vigabatrin
Generic Name vigabatrin
Labeler amneal pharmaceuticals ny llc
Dosage Form FOR SOLUTION
Routes
ORAL
Active Ingredients

vigabatrin 500 mg/1

Manufacturer
Amneal Pharmaceuticals NY LLC

Identifiers & Regulatory

Product NDC 60219-1425
Product ID 60219-1425_3bf642d5-5597-4668-a4ab-d240699a395e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210155
Listing Expiration 2026-12-31
Marketing Start 2023-12-07

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 602191425
Hyphenated Format 60219-1425

Supplemental Identifiers

RxCUI
250820
UPC
0360219142558 0360219142510
UNII
GR120KRT6K
NUI
N0000175753

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vigabatrin (source: ndc)
Generic Name vigabatrin (source: ndc)
Application Number ANDA210155 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/1
source: ndc
Packaging
  • 50 FOR SOLUTION in 1 CARTON (60219-1425-5)
source: ndc

Packages (1)

Ingredients (1)

vigabatrin (500 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3bf642d5-5597-4668-a4ab-d240699a395e", "openfda": {"nui": ["N0000175753"], "upc": ["0360219142558", "0360219142510"], "unii": ["GR120KRT6K"], "rxcui": ["250820"], "spl_set_id": ["9791494f-492b-487a-8211-7747fb57923e"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 FOR SOLUTION in 1 CARTON (60219-1425-5)", "package_ndc": "60219-1425-5", "marketing_start_date": "20231207"}], "brand_name": "Vigabatrin", "product_id": "60219-1425_3bf642d5-5597-4668-a4ab-d240699a395e", "dosage_form": "FOR SOLUTION", "pharm_class": ["Anti-epileptic Agent [EPC]"], "product_ndc": "60219-1425", "generic_name": "Vigabatrin", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Vigabatrin", "active_ingredients": [{"name": "VIGABATRIN", "strength": "500 mg/1"}], "application_number": "ANDA210155", "marketing_category": "ANDA", "marketing_start_date": "20231207", "listing_expiration_date": "20261231"}